Gary Ingenito - Net Worth and Insider Trading
Gary Ingenito Net Worth
The estimated net worth of Gary Ingenito is at least $1 Million dollars as of 2024-11-10. Gary Ingenito is the Chief Med. & Reg. Officer of Catalyst Pharmaceuticals Inc and owns about 51,391 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $1 Million. Details can be seen in Gary Ingenito's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gary Ingenito has not made any transactions after 2024-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gary Ingenito
Gary Ingenito Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gary Ingenito owns 1 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) .
Click here to see the complete history of Gary Ingenito’s form 4 insider trades.
Insider Ownership Summary of Gary Ingenito
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2024-08-09 | Chief Medical Officer |
Gary Ingenito Latest Holdings Summary
Gary Ingenito currently owns a total of 1 stock. Gary Ingenito owns 51,391 shares of Catalyst Pharmaceuticals Inc (CPRX) as of August 9, 2024, with a value of $1 Million.
Latest Holdings of Gary Ingenito
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2024-08-09 | 51,391 | 23.93 | 1,229,787 |
Holding Weightings of Gary Ingenito
Gary Ingenito Form 4 Trading Tracker
According to the SEC Form 4 filings, Gary Ingenito has made a total of 11 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 100,000 shares on August 9, 2024, which brought Gary Ingenito around $2 Million.
Insider Trading History of Gary Ingenito
- 1
Gary Ingenito Trading Performance
Gary Ingenito Ownership Network
Ownership Network List of Gary Ingenito
Ownership Network Relation of Gary Ingenito
Gary Ingenito Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
Gary Ingenito is the Chief Medical Officer of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include VP Development & Management Steve Miller , Chief Commercial Officer Carmen Jeffrey Del , and Chief Compliance/Legal Officer Brian Elsbernd .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, Gary Ingenito made 3 insider transaction in Catalyst Pharmaceuticals Inc (CPRX) with a net sale of 230,000. Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 90,000 shares made by David S Tierney , a net sale of 190,000 shares made by Steve Miller , and a net sale of 43,599 shares made by Carmen Jeffrey Del .
In summary, during the past 3 months, insiders sold 165,000 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 165,000 shares. During the past 18 months, 741,406 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 741,406 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
Gary Ingenito Mailing Address
Above is the net worth, insider trading, and ownership report for Gary Ingenito. You might contact Gary Ingenito via mailing address: 355 Alhambra Circle, Suite 1500, Coral Gables Fl 33134.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
